First Time Loading...

Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 4.08 USD 1.24%
Updated: May 6, 2024

Abcellera Biologics Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abcellera Biologics Inc
Net Income (Common) Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Net Income (Common)
-$146.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Net Income (Common)
-CA$5.5m
CAGR 3-Years
14%
CAGR 5-Years
-10%
CAGR 10-Years
-39%
Replicel Life Sciences Inc
XTSX:RP
Net Income (Common)
-CA$69.3k
CAGR 3-Years
69%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Net Income (Common)
-CA$211.1k
CAGR 3-Years
N/A
CAGR 5-Years
-9%
CAGR 10-Years
14%

See Also

What is Abcellera Biologics Inc's Net Income (Common)?
Net Income (Common)
-146.4m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Net Income (Common) amounts to -146.4m USD.